Angela Kaya, the Director of Publications & ScientificCommunications at PMV Pharma, has firsthand experience with the benefits of LARVOL CONF. Her insights provide a valuable perspective on how this tool can make a real difference in managing conference-related information. From keeping track of disease-specific sessions to filtering through abstracts and staying on top of post-conference activities, PMV Pharma’s experience with LARVOL CONF is a testament to its practicality and efficiency.

In this discussion, we aim to uncover the real-world impact of LARVOL CONF on the day-to-day activities of a pharmaceutical professional. PMV Pharma’s story is not just about a tool, but about finding smarter ways to access and use information, making the most of every conference attended.

‍

LARVOL: To kick things off, can you provide a brief overview of PMV Pharma and explain what motivated you to use LARVOL’s conference planners?

PMV Pharma: Certainly! PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor agnostic therapies targeting p53. Our lead investigational agent is PC14586 – a first-in-class, small molecule p53 reactivator. It is designed to selectively bind to the pocket found in the p53 Y220C mutant protein. This binding restores the wild-type, or normal, p53 protein structure, and hence, reinstates its tumor-suppressing function. Our prior positive experiences with LARVOL’s CONF drew us back. Both our Senior Vice President of Clinical Development and Medical Affairs and I have leveraged your conference planners previously and found them invaluable. They provide a unified format for our conference-goers, ensuring we don't miss out on important sessions and insights. Given these endorsements, it was a logical choice for PMV Pharmaceuticals.

‍

LARVOL: Before bringing our planners onboard, particularly for ASCO 2023, did you face any conference planning challenges?

PMV Pharma: Absolutely. We hadn't used any conference planners before and only relied on the information provided by individual conferences, like ASCO. This involved manual scheduling and navigation, which wasn't efficient. LARVOL's planners allowed us to identify crucial presentations and schedule them seamlessly, especially during packed events like ASCO.

‍

LARVOL: How was your experience integrating ourplanners internally? Was it a steep learning curve?

PMV Pharma: Integration was straightforward. We distributed versions and informed the team of any updates. As for feedback, we intend to gather it by year-end, but based on our communications, the team has taken to it quite well. Overall, the process seemed smooth.

LARVOL: Did you personally use the planner or was it primarily your team? How did it assist in your ASCO planning?

PMV Pharma: I definitely used it. The planner's keyword feature helped streamline the list of sessions. The Excel format let me drill down further, ensuring I prioritized sessions efficiently. In case of conflicts, the planner ensured all vital sessions were covered.

LARVOL: Our team is continually aiming to improve. Were there any specific features or analytics in the planners that stood out?

PMV Pharma: Absolutely. While I haven't explored product analytics, I can see their value, especially during debriefs. The ability to search titles, MOAs, and biomarkers was particularly useful for me. It's interesting how some fields are auto-generated, providing more insights than conference-provided tools.

LARVOL: Your insight is invaluable. How would you describe your interactions with our team, especially our CSS team?

PMV Pharma: It's been fantastic. The planners met our expectations, given our prior experience. Your plans to transition to a continually updated web-based format will be a game-changer, ensuring we always work with the most recent data.

LARVOL: We're looking forward to launching that.Would you endorse our conference planners to other businesses?

PMV Pharma: Without a doubt! Duplication of efforts is inefficient and CONF reduces redundancy. As teams grow, using a unified resource like LARVOL’s planner becomes pivotal. It promotes collaboration and saves time. To companies considering multiple platforms: Why pay twice when LARVOL provides comprehensive solutions?

LARVOL: Finally, as we're always looking to refine our offerings, are there any features or tweaks you'd like to see in the future?

PMV Pharma: My main concern was choosing the right planner version, but the upcoming online platform should address that by offering real-time updates.

LARVOL: Thank Angela, your feedback is invaluable. We appreciate you sharing your experience with our audience.

PMV Pharma: The pleasure is ours. We’re excited about our continued collaboration.